Skip to content
HowShorted

Keros Therapeutics, Inc. short interest in 2026

In 2026, Keros Therapeutics, Inc.'s disclosed short interest ran from 7.70% of shares outstanding on 15 Jan 2026 to 6.77% on 15 Sep 2026, a change of -0.93 percentage points. The year's high was 10.30% on 27 Feb 2026 and its low 4.97% on 31 Jul 2026, averaging 7.22% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.13 days on 15 Sep 2026. Full history: Keros Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Keros Therapeutics, Inc. in 2026

2026 in figures

Start of year
7.70% (15 Jan 2026)
End of year
6.77% (15 Sep 2026)
Change
-0.93 pp
High
10.30% (27 Feb 2026)
Low
4.97% (31 Jul 2026)
Average
7.22%
Highest days to cover
9.13 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Keros Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20267.70%5.25
30 Jan 20267.47%8.84
13 Feb 20267.82%8.82
27 Feb 202610.30%6.60
13 Mar 202610.09%3.5210-K filed, results (8-K)
31 Mar 20267.58%2.63
15 Apr 20267.10%3.47
30 Apr 20267.18%5.36
15 May 20268.64%4.6510-Q filed, results (8-K)
29 May 20267.65%4.54
15 Jun 20267.14%6.60
30 Jun 20265.21%2.54
15 Jul 20265.37%4.08
31 Jul 20264.97%5.92
14 Aug 20265.79%4.7310-Q filed, results (8-K)
31 Aug 20265.88%6.09
15 Sep 20266.77%9.13

See also: Keros Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.